Loading...

Financial Summary


Abbott Laboratories

Abbott Laboratories (ABT)

Healthcare
Buy
A
Market Info
Financial Info
Financial Modelling
Symbol ABT
Price 84.63$
Beta 1.11
Volume Avrg. 4.68M
Market Cap 149.66B
Shares (2019) 1,781,000.00K
Last Div 1.28
Dividend Yield 1.52%
DCF Unlevered 52.96 Strong Sell
DCF Levered 65.47 Sell
ROE NaN%
ROA NaN%
Operating Margin 14.21% Buy
Debt / Equity NaN%
P/E -
P/B -

Income Statement

Download ABT income statement Download ABT income statement
Year 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
Earnings Per Share Basic 3.712.983.033.761.641.502.940.940.271.342.07
Net Profit Margin 0.190.130.120.150.120.110.220.070.020.080.12
Earnings Per Share Diluted 3.692.963.013.721.621.492.920.940.271.332.06
Revenue 30,764.7135,166.7238,851.2639,873.9121,848.0020,247.0020,405.0020,853.0027,390.0030,578.0031,904.00
Weighted Average Shares Outstanding 1,546.741,546.401,557.641,575.381,558.001,516.001,496.001,477.001,740.001,758.001,768.00
Gross Profit 17,555.3820,188.3322,638.1824,466.1911,017.0010,474.0011,057.0011,279.0013,078.0015,694.0016,737.00
Weighted Average Shares Outstanding (Diluted) 1,546.981,556.021,567.391,591.841,574.001,527.001,506.001,483.001,749.001,770.001,781.00
Sales, General and Administrative Expense 8,405.9010,376.3212,756.8212,059.506,936.006,530.006,785.006,672.009,117.009,744.009,765.00
Dividend per Share 0.000.000.000.000.000.000.000.000.000.000.00
Operating Income 6,235.746,087.585,751.958,084.522,629.002,599.002,867.003,185.001,726.003,650.004,532.00
Gross Margin 0.570.570.580.610.500.520.540.540.480.510.52
Earnings before Tax 7,193.774,626.175,198.646,262.612,521.002,518.003,183.001,413.002,231.002,873.004,077.00
EBITDA Margin 0.320.250.230.270.200.200.210.230.210.230.24
Net Income 5,745.844,626.174,728.455,962.922,576.002,284.004,423.001,400.00477.002,368.003,687.00
EBIT Margin 0.250.170.150.200.120.130.140.150.060.120.14
Net Income - Discounted ops -----------
Profit Margin 0.190.130.120.150.120.110.220.070.020.080.12
Preferred Dividends -----------
Free Cash Flow margin 0.000.000.000.000.000.000.000.000.000.000.00
R&D Expenses 2,743.733,724.424,129.414,322.181,452.001,345.001,405.001,422.002,235.002,300.002,440.00
Interest Expense 519.66553.13530.14592.40157.00150.00163.00431.00904.00826.00670.00
Earnings Before Tax Margin 0.230.130.130.160.120.120.160.070.080.090.13
Consolidated Income 5,745.844,626.174,728.455,962.922,576.002,284.004,423.001,400.00477.002,368.003,687.00
EBIT 7,713.436,087.585,751.958,084.522,629.002,599.002,867.003,185.001,726.003,650.004,532.00
EBITDA 9,802.948,711.898,795.8410,867.724,348.004,147.004,339.004,703.005,659.006,960.007,546.00
Income Tax Expense 1,447.941,086.66470.19299.69138.00797.00577.00350.001,878.00539.00390.00
Operating Expenses 11,319.6414,100.7516,886.2316,381.688,388.007,875.008,190.008,094.0011,352.0012,044.0012,205.00
Cost of Revenue 13,209.3314,978.3916,213.0815,407.7210,831.009,773.009,348.009,574.0014,312.0014,884.0015,167.00
Net Income Com 5,745.844,626.174,728.455,962.922,576.002,284.004,423.001,400.00477.002,368.003,687.00
Net Income - Non-Controlling int -----------

Balance Sheet Statement

Download ABT income statement Download ABT income statement
Year 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
Total current liabilities 13,049.4917,262.4315,480.2313,280.189,507.0010,532.009,186.006,660.008,912.009,012.0010,863.00
Other Liabilities 6,579.33-2,987.72-2,614.23-2,893.95-2,425.00-1,484.00-2,639.00-2,107.00-415.007,003.008,739.00
Long-term debt 11,266.2912,523.5212,039.8218,085.303,388.003,408.005,871.0020,681.0027,210.0019,359.0016,661.00
Cash and cash equivalents 9,932.053,648.376,812.8210,802.163,475.004,063.005,001.0018,620.009,407.003,844.003,860.00
Total debt 16,455.9114,568.4913,066.7218,394.133,397.003,463.005,874.0020,684.0027,718.0019,366.0017,938.00
Cash and short-term investments 9,932.055,451.458,097.3615,173.983,501.004,460.006,125.0018,775.009,610.004,164.004,140.00
Deferred revenue ---------259.00294.00
Inventories 3,264.883,188.733,284.253,792.312,693.002,643.002,599.002,434.003,601.003,796.004,316.00
Tax Liabilities 442.141,307.72514.95655.42175.00270.00430.00188.00309.00305.00226.00
Goodwill and Intangible Assets 19,492.1628,081.7125,695.0224,362.4115,507.0016,265.0015,200.0012,222.0045,493.0042,196.0040,225.00
Deposit Liabilities -----------
Tax assets 3,387.363,076.052,700.542,986.222,528.001,705.004,383.002,263.001,944.001,868.003,079.00
Total non-current liabilities 16,344.7422,799.4222,971.0630,127.7510,700.0010,701.0013,489.0027,575.0036,856.0020,634.0017,197.00
Total current assets 23,313.8922,317.5323,768.7731,322.5819,247.0015,261.0014,155.0026,776.0020,147.0014,632.0015,667.00
Total liabilities 29,394.2337,074.1335,837.0640,513.9817,782.0019,749.0020,036.0032,128.0045,353.0036,649.0036,799.00
Payables 1,280.541,535.761,721.131,796.991,026.001,064.001,081.001,178.002,402.002,975.003,252.00
Other comprehensive income 854.07----------
Short-term investments -1,803.081,284.544,371.8226.00397.001,124.00155.00203.00320.00280.00
Retained earnings (deficit) 17,342.6918,927.1020,907.3624,151.0021,979.0022,874.0025,757.0025,565.0023,978.0024,560.0025,847.00
Property, Plant & Equipment Net 7,619.497,970.967,873.958,063.055,905.005,935.005,730.005,705.007,607.007,563.008,038.00
Total non-current assets 29,267.7337,144.7436,508.1235,912.3623,706.0026,014.0027,092.0025,890.0056,103.0052,541.0052,220.00
Other Assets 3,575.03----------
Net Debt 6,523.8710,920.126,253.907,591.96-78.00-600.00873.002,064.0018,311.0015,522.0014,078.00
Investments 1,132.872,105.131,662.764,645.4226.00626.005,165.003,102.001,086.00531.001,163.00
Total shareholders equity 23,187.4022,388.1324,439.8326,720.9625,171.0021,526.0021,211.0020,538.0030,897.0030,524.0031,088.00
Total assets 52,581.6259,462.2760,276.8967,234.9442,953.0041,275.0041,247.0052,666.0076,250.0067,173.0067,887.00
Long-term investments 1,132.87302.05378.23273.60-229.004,041.002,947.00883.00211.00883.00
Receivables 6,541.947,184.037,683.927,612.863,986.003,586.003,418.003,248.005,249.005,182.005,425.00
Short-term debt 5,189.622,044.971,026.90308.829.0055.003.003.00508.007.001,277.00

Cash Flow Statement

Download ABT income statement Download ABT income statement
Year 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
Insurance (repayment) of debt -----------
Net Cash/Marketcap -0.00----------
Insurance (buybacks) of shares -----------
Depreciation & Amortization 2,089.512,624.303,043.892,783.211,719.001,548.001,472.001,518.003,933.003,310.003,014.00
Dividend payments -2,414.46-2,671.47-2,938.10-3,182.81-882.00-1,342.00-1,443.00-1,539.00-1,849.00-1,974.00-2,270.00
Operating Cash Flow 7,275.168,735.988,970.089,314.403,324.003,675.002,966.003,203.005,570.006,300.006,136.00
Acquisitions and disposals -2,370.63-9,433.24-672.50-1,227.47-580.00-3,317.00-235.00-80.00-17,183.00--
Free Cash Flow 6,186.117,720.917,478.587,519.112,179.002,598.001,856.002,082.004,435.004,906.004,498.00
Net cash flow / Change in cash 4,697.32-5,160.973,164.4510,802.16-7,327.00588.00938.0013,619.00-9,213.00-5,563.0016.00
Effect of forex changes on cash 118.85-620.89-43.0140.14-26.00-143.00-198.00-483.00116.00-116.00-16.00
Financing Cash Flow 1,002.02-1,087.74-6,023.45716.09-6,696.00-2,742.00-2,236.0011,147.00-5,281.00-10,391.00-4,289.00
Investment purchases and sales -232.66-1,672.76-5,186.99-14,361.89-11,669.00-3,702.00-7,170.00-3,345.00-327.00-369.00-800.00
Capital Expenditure -1,089.051,015.081,491.501,795.291,145.001,077.001,110.001,121.001,135.001,394.001,638.00
Stock-based compensation 366.36387.18382.60433.11262.00246.00292.00310.00406.00477.00519.00
Investing Cash Flow -----------

Retained Earning Schedule

Year 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
Retained Earnings (Previous Year) -17,34318,92720,90724,15121,97922,87425,75725,56523,97824,560
Net Income 5,7464,6264,7285,9632,5762,2844,4231,4004772,3683,687
Stock Dividends 14,011-370190464-3,866-47-97-53-215188-130
Divident Paid -2,414-2,671-2,938-3,183-882-1,342-1,443-1,539-1,849-1,974-2,270
Retained Earnings 17,34318,92720,90724,15121,97922,87425,75725,56523,97824,56025,847

PPE Schedule

Year 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
Year 20092010201120122013201420152016201720182019
Gross PPE -7,6197,9717,8748,0635,9055,9355,7305,7057,6077,563
Annual Depreciation 8,709-664-1,589-1,606-3,303-1,047-1,315-1,146767-1,438-1,163
Capital Expenditure -1,0891,0151,4921,7951,1451,0771,1101,1211,1351,3941,638
Net PPE 7,6197,9717,8748,0635,9055,9355,7305,7057,6077,5638,038

Intangible and Goodwill Schedule

Year 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
Intangible and Goodwill (Previous Year) -19,49228,08225,69524,36215,50716,26515,20012,22245,49342,196
New Purchases -233-1,673-5,187-14,362-11,669-3,702-7,170-3,345-327-369-800
Intangible and Goodwill 19,49228,08225,69524,36215,50716,26515,20012,22245,49342,19640,225
Abbott Laboratories

Abbott Laboratories (ABT)

84.63
-2.82 (-3.22%)

About


Miles D. White
Healthcare
Drug Manufacturers
New York Stock Exchange

Abbott Laboratories is a health care company that manufactures medical devices, blood glucose monitoring kits, nutritional healthcare products, diagnostic products and equipment, and branded generic drugs.